Venture Life Group
Venture Life Group plc is a UK-based, AIM-listed branded consumer self-care company developing and distributing 60 OTC products across 8 brands — spanning women's healthcare, glucose management, ENT care, and oncology support — through UK retail partners and international pharmaceutical distributors in 90+ countries.
- Company typePublic
- Founded2010
- HeadquartersBracknell, United Kingdom
- Headcount101–250
- GTM typeB2C
- OfferingHardware or Manufacturing
What Venture Life Group does
Venture Life Group plc is a UK-headquartered (Bracknell) AIM-listed consumer self-care company that develops, manufactures through third-party partners, and distributes a portfolio of 8 brands and 60 products across 90+ countries. The portfolio spans four therapeutic verticals: women's intimate healthcare (vonalei, Balance Activ, Health & Her/Him, FemiClear, CUROXEN), glucose management for hypoglycaemia (Lift Glucose shots/tablets, Glucogel), ENT care (Earol® metered-dose olive oil spray, EarolSwim® water-repellent spray), and oncology support (Gelclair oral mucositis rinse, Pomi-T for PSA management, Xonrid). Revenue is split 56% from medical-device-classified products and 44% from food supplements, sold through omnichannel retail and pharmacy distribution.
The company operates an asset-light branded model following the 2025 divestiture of its lower-margin CDMO operations for €62 million. UK revenues of £25.7 million grew 20.7% in 2025, with Power Brands growing 14.9% to £33.1 million, supported by direct retailer partnerships (Boots, Superdrug, Tesco, Sainsbury's, Asda, Morrisons) and international distribution through tier-1 pharmaceutical partners (Bayer, Almirall, Viatris, Menarini, Sunstar, Phoenix, AAH). Products are clinically validated (Pomi-T double-blind RCT, Glucogel hospital use over 25 years) and protected by registered trademarks. Go-to-market combines direct retail relationships in the UK, USA, and EU with a B2B distributor model internationally and Amazon for online direct-to-consumer sales.
Financially, the business generated £35.1 million of revenue in 2025 (32% YoY growth), £6.2 million adjusted EBITDA on FY2024 continued operations, and holds £34.4 million net cash entering 2026 with an active bolt-on M&A pipeline that has already added Health & Her/Him (November 2024) and CUROXEN/FemiClear (June 2026). Capital allocation has included a £1.1 million share buyback, and ownership is dispersed among institutional investors with Slater Investments (~29.4%) and BGF Investments (~9.5%) as anchor shareholders. The company is led by CEO Jerry Randall, CFO Daniel Wells, and Executive Chairman Paul McGreevy.
Venture Life Group firmographics
Firmographics- Name
- Venture Life Group
- Legal name
- Venture Life Group plc
- Website
- https://venture-life.com
- Company type
- Public
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Venture Life Group plc is a UK-based, AIM-listed branded consumer self-care company developing and distributing 60 OTC products across 8 brands — spanning women's healthcare, glucose management, ENT care, and oncology support — through UK retail partners and international pharmaceutical distributors in 90+ countries.
- Ownership category
- akta.pro rank
Venture Life Group industry classification
Industry- Product category
- Consumer Healthcare Products
- NAICS
- Food (Health) Supplement Retailers (456191), Pharmacies and Drug Retailers (456110), Health and Personal Care Retailers (4561)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK)
- akta.pro secondary industries
- Vitamins & Minerals (Single Nutrients) (CRADAGAB), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Health Food & Supplement Stores (CRAHAEAC)
Keywords
Where Venture Life Group is headquartered
LocationHeadquarters
- HQ city
- Bracknell
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Venture Life Group business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- Power Brands Portfolio Sales: Revenue from branded consumer healthcare products including Balance Activ, Lift/Glucogel, Earol, and Health & Her/Him. Power Brands portfolio grew 14.9% to £33.1 million in 2025.
- OTC Healthcare Products: 56% revenue from medical devices, 44% from supplements. Products distributed through retail and pharmacy channels globally.
- International Distribution: B2B international business model through distribution partners in markets outside UK, USA and EU. Partners cover local marketing and distribution costs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Consumer healthcare products sold through retail channels |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Venture Life Group product offering
Product offeringCore offering
Venture Life Group develops, manufactures and distributes branded, non-prescription consumer self-care products across four therapeutic areas: Women's Healthcare (vonalei), Glucose Management (Lift Glucose shots/tablets and Glucogel 40% dextrose gel), ENT Care (Earol and EarolSwim metered-dose olive oil sprays) and Oncology Support (Gelclair oral rinse and Pomi-T food supplement). The portfolio comprises 8 brands and 60 products, with 56% of revenue from medical devices and 44% from food supplements, sold through pharmacies, grocery retailers, and international distributors in over 90 countries.
Product overview
Venture Life Group is a pure branded consumer healthcare business that develops and distributes non-drug, prescription-free products for the global self-care market. The company operates across 8 brands and 60 products, with 56% of revenue from medical devices and 44% from supplements. The product portfolio spans four key therapeutic areas: Women's Healthcare (vonalei for bacterial vaginosis, vaginal atrophy, candidiasis), Glucose Management (Lift Glucose products and Glucogel for hypoglycaemia), ENT Care (Earol® and EarolSwim® for ear wax removal and swimmer's ear protection), and Oncology Support (Pomi-T, Gelclair, and Xonrid for cancer treatment side effects). The company sells through omnichannel distribution in key markets (UK, USA, EU) via retailers and distributors, with products available in over 90 countries worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- vonalei: Women's healthcare products including treatments for Bacterial Vaginosis, Vaginal Atrophy, Candidiasis, and Intimate Cleansing Foam.
- Lift Glucose
- Glucogel
- Earol
- EarolSwim
- Pomi-T
- Gelclair
- Xonrid
- Balance Activ
- Health & Her/Him
Products and services
- vonalei
Quantifiable outcome
- Revenue of £35.1 million in 2025, representing 32% year-on-year increase
- +4 more outcomes
Companies that use Venture Life Group
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles3 records
Venture Life Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Venture Life Group partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered core.
- AlliancecoreInternational pharmaceutical/healthcare distribution partner for Venture Life products in certain markets.
- BayercorePharmaceutical partner distributing Venture Life products internationally through healthcare channels.
- AlmirallcorePharmaceutical partner for international distribution of self-care products.
- SunstarcoreHealthcare distribution partner for Venture Life product portfolio.
- MenarinicoreInternational pharmaceutical distributor for consumer healthcare products.
- ViatriscoreGlobal healthcare partner distributing Venture Life products internationally.
- BootscoreUK pharmacy retail partner with direct distribution relationship. Venture Life invests in advertising and promotion.
- SuperdrugcoreUK pharmacy retail partner for consumer healthcare products.
- TescocoreUK grocery retail partner for product distribution through supermarket channels.
- Sainsbury'scoreUK grocery retail partner for product availability in supermarkets.
- AsdacoreUK grocery retail partner for product distribution.
- MorrisonscoreUK grocery retail partner for product availability.
- AmazoncoreE-commerce platform partner for online product sales globally.
- PhoenixcoreEuropean pharmaceutical wholesaler and distributor partner.
- FarmaciacorePharmacy distribution partner for European markets.
- CoopercoreHealthcare product distributor partner.
- AAHcoreUK pharmaceutical wholesaler and distributor.
Scale indicators10 records
Recent moves6 records
Expansion highlights4 records
Venture Life Group competitors and assessment
Company assessmentBroad incumbents
- Church & Dwight: US-listed CPG company with consumer healthcare brands (Batiste, First Response, Trojan). Comparable as a multi-brand consumer healthcare company with retail and pharmacy distribution, though much larger.
- Haleon: Global consumer healthcare leader (formerly GSK Consumer Healthcare) with brands like Sensodyne, Centrum, and Voltaren. Comparable as a broad incumbent in consumer self-care and OTC medical devices/supplements, though much larger scale than Venture Life.
- Bayer Consumer Health: Pharmaceutical company's consumer health division with brands like Claritin, Aspirin, and Bepanthen. Comparable in offering OTC self-care brands globally; already a distribution partner for Venture Life products.
- Perrigo Company: Large OTC consumer healthcare and self-care products manufacturer. Comparable in offering consumer self-care brands across multiple therapeutic categories and operating in the pharmacy/retail channel globally.
- Mylan (now Viatris) Consumer Healthcare: Global healthcare company offering OTC consumer healthcare products. Comparable as a broad incumbent with self-care brands; existing distribution partner for Venture Life.
- Sanofi Consumer Healthcare: Global pharmaceutical company with significant consumer healthcare (CHC) segment including brands like Doliprane and Mucosolvan. Comparable in offering OTC self-care products across multiple categories globally.
Direct peers
- Omega Pharma (now Perrigo): European OTC healthcare company with portfolio of self-care brands. Direct comparable as a mid-sized European consumer healthcare company focused on pharmacy channels.
- Prestige Consumer Healthcare: US-based OTC consumer healthcare company with a portfolio of branded self-care products across multiple therapeutic areas. Closely comparable business model as a focused branded consumer healthcare rollup in similar size category.
- Recordati Industria Chimica: European specialty pharmaceutical company with consumer healthcare focus, particularly in women's health and self-care OTC products. Comparable in size and therapeutic verticals (women's health, specialty self-care).
Regional players
- Diurnal Group: UK-based specialty pharmaceutical company focused on endocrine and rare disease treatments. Comparable as a small UK-listed healthcare company focused on specialty therapeutic areas with similar size and listing structure (AIM).
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Venture Life Group social profiles
Digital presenceVenture Life Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Venture Life Group leadership team
Management profileNumber of profiles
Profiles5 records
Venture Life Group subsidiaries and ownership
Company hierarchySubsidiaries1 record
Venture Life Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Venture Life Group M&A and investment
M&A and investmentM&A6 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Venture Life Group
What does Venture Life Group do?
Venture Life Group develops, manufactures and distributes branded, non-prescription consumer self-care products across four therapeutic areas: Women's Healthcare (vonalei), Glucose Management (Lift Glucose shots/tablets and Glucogel 40% dextrose gel), ENT Care (Earol and EarolSwim metered-dose olive oil sprays) and Oncology Support (Gelclair oral rinse and Pomi-T food supplement). The portfolio comprises 8 brands and 60 products, with 56% of revenue from medical devices and 44% from food supplements, sold through pharmacies, grocery retailers, and international distributors in over 90 countries.
Is Venture Life Group a public or private company?
Venture Life Group is a public company. It is classified as public and is currently operating.
When was Venture Life Group founded?
Venture Life Group was founded in 2010. It employs 101 to 250 people.
Where is Venture Life Group based?
Venture Life Group is headquartered in Bracknell, United Kingdom, in the Europe region.
How does Venture Life Group make money?
Three revenue lines are on record. Power Brands Portfolio Sales are the primary driver. The others are OTC Healthcare Products and international Distribution.
Who are Venture Life Group's main competitors?
Broad incumbents on record are Church & Dwight, Haleon, Bayer Consumer Health, Perrigo Company, Mylan (now Viatris) Consumer Healthcare and Sanofi Consumer Healthcare. Direct peers are Omega Pharma (now Perrigo), Prestige Consumer Healthcare and Recordati Industria Chimica. Diurnal Group is listed as a regional player.
Does Venture Life Group have an API?
No public API is recorded for Venture Life Group.
What industry is Venture Life Group in?
Venture Life Group's product category is Consumer Healthcare Products. Its primary akta.pro industry code is CRADAGAK, Women’s Health Supplements (Prenatal, Menopause, Hormonal), with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 456191 and its SIC code is 2834.